The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study
Open accessAbstract
BACKGROUND: Plasmodium vivax exacts a significant toll on health worldwide, yet few efforts to date have quantified the extent and temporal trends of its global distribution. Given the challenges associated with the proper diagnosis and treatment of P vivax, national malaria programmes-particularly those pursuing malaria elimination strategies-require up to date assessments of P vivax endemicity and disease impact. This study presents the first global maps of P vivax clinical burden from 2000 to 2017. METHODS: In this spatial and temporal modelling study, we adjusted routine malariometric surveillance data for known biases and used socioeconomic indicators to generate time series of the clinical burden of P vivax. These data informed Bayesian geospatial models, which produced fine-scale predictions of P vivax clinical incidence and infection prevalence over time. Within sub-Saharan Africa, where routine surveillance for P vivax is not standard practice, we combined predicted surfaces of Plasmodium falciparum with country-specific ratios of P vivax to P falciparum. These results were combined with surveillance-based outputs outside of Africa to generate global maps. FINDINGS: We present the first high-resolution maps of P vivax burden. These results are combined with those for P falciparum (published separately) to form the malaria estimates for the Global Burden of Disease 2017 study. The burden of P vivax malaria decreased by 41·6%, from 24·5 million cases (95% uncertainty interval 22·5-27·0) in 2000 to 14·3 million cases (13·7-15·0) in 2017. The Americas had a reduction of 56·8% (47·6-67·0) in total cases since 2000, while South-East Asia recorded declines of 50·5% (50·3-50·6) and the Western Pacific regions recorded declines of 51·3% (48·0-55·4). Europe achieved zero P vivax cases during the study period. Nonetheless, rates of decline have stalled in the past five years for many countries, with particular increases noted in regions affected by political and economic instability. INTERPRETATION: Our study highlights important spatial and temporal patterns in the clinical burden and prevalence of P vivax. Amid substantial progress worldwide, plateauing gains and areas of increased burden signal the potential for challenges that are greater than expected on the road to malaria elimination. These results support global monitoring systems and can inform the optimisation of diagnosis and treatment where P vivax has most impact. FUNDING: Bill & Melinda Gates Foundation and the Wellcome Trust.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most P. vivax cases are in geographic areas of the WHO Regional Offices for South-East Asia and Eastern Mediterranean [19]”
From Global estimates of pregnancies at risk of Plasmodium falciparum and Plasmodium vivax infection in 2020 and changes in risk patterns since 2000 (2022) · cites this paper as [19]
In the citing paper
“Since 2007 there have been decreases in the prevalence of P. falciparum [12] and P. vivax [19], as well as global fertility rates [21, 22], although absolute populations have grown at regional and global levels.”
From Global estimates of pregnancies at risk of Plasmodium falciparum and Plasmodium vivax infection in 2020 and changes in risk patterns since 2000 (2022) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citationThe effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015
Bhatt, S., Weiss, D. J., Cameron, E., Bisanzio, D., Mappin, B., Dalrymple, U., Battle, K. E., Moyes, C. L., Henry, A., Eckhoff, P. A., et al. (2015) · Nature · doi:10.1038/nature15535 · Cited by 3,225
Self-citationThe Resistance Factor toPlasmodium vivaxin Blacks
Miller, L. H., Mason, S. J., CLYDE, D. F., & McGinniss, M. H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608052950602 · Cited by 1,259
The global distribution and population at risk of malaria: past, present, and future
Hay, S. I., Guerra, C. A., Tatem, A. J., Noor, A. M., & Snow, R. W. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01043-6 · Cited by 1,002
The neglected burden of Plasmodium vivax malaria
Mendis, K., Sina, B. J., Marchesini, P. B., & Carter, R. (2001) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.97 · Cited by 976
Vivax Malaria: Neglected and Not Benign
Price, R. N., Tjitra, E., Guerra, C. A., Yeung, S., White, N. J., & Anstey, N. M. (2007) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.79 · Cited by 840
Asymptomatic malaria infections: detectability, transmissibility and public health relevance
Bousema, T., Okell, L., Felger, I., & DRAKELEY, C. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3364 · Cited by 685
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite
Müeller, I., Galinski, M. R., Baird, J. K., Carlton, J. M., Kochar, D. K., Alonso, P. L., & Portillo, H. A. D. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70177-x · Cited by 661
A Long Neglected World Malaria Map: Plasmodium vivax Endemicity in 2010
Gething, P. W., Elyazar, I., Moyes, C. L., Smith, D. L., Battle, K. E., Guerra, C. A., Patil, A. P., Tatem, A. J., Howes, R. E., Myers, M. F., et al. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001814 · Cited by 560
Self-citation
Cited by
Sorted by citations
Weiss, D. J., Lucas, T. C. D., Nguyen, M., Nandi, A. K., Bisanzio, D., Battle, K. E., Cameron, E., Twohig, K. A., Pfeffer, D. A., Rozier, J. A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31097-9 · Cited by 469
Self-citationMalaria eradication within a generation: ambitious, achievable, and necessary
Feachem, R. G., Chen, I., Akbari, O. S., Bertozzi-Villa, A., Bhatt, S., Binka, F. N., Boni, M. F., Buckee, C. O., Dieleman, J. L., Dondorp, A. M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31139-0 · Cited by 372
Plasmodium vivax in the Era of the Shrinking P. falciparum Map
Price, R. N., Commons, R. J., Battle, K. E., Thriemer, K., & Mendis, K. (2020) · Trends in Parasitology · doi:10.1016/j.pt.2020.03.009 · Cited by 270
Self-citationMalaria vaccines since 2000: progress, priorities, products
Duffy, P. E., & Gorres, J. P. (2020) · npj Vaccines · doi:10.1038/s41541-020-0196-3 · Cited by 267
Weiss, D. J., Bertozzi-Villa, A., Rumisha, S. F., Amratia, P., Arambepola, R., Battle, K. E., Cameron, E., Chestnutt, E., Gibson, H. S., Harris, J., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30700-3 · Cited by 236
Self-citationmRNA vaccines for infectious diseases — advances, challenges and opportunities
Pardi, N., & Krammer, F. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01042-y · Cited by 252
Favuzza, P., Ruiz, M. D. L., Thompson, J. K., Triglia, T., Ngo, A., Steel, R. W. J., Vavrek, M., Christensen, J. B., Healer, J., Boyce, C. W., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.02.005 · Cited by 153
Li, J., Docile, H. J., Fisher, D. P., Pronyuk, K., & Zhao, L. (2024) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-024-00228-2 · Cited by 180
Commons, R. J., Simpson, J. A., Watson, J. A., White, N. J., & Price, R. N. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-0186 · Cited by 150
8-Aminoquinoline Therapy for Latent Malaria
Baird, J. K. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00011-19 · Cited by 138
Pathophysiology and neurologic sequelae of cerebral malaria
Schiess, N., Villabona-Rueda, A. F., Cottier, K. E., Huether, K., Chipeta, J., & Stins, M. F. (2020) · Malaria Journal · doi:10.1186/s12936-020-03336-z · Cited by 117
Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination
Duffy, P. E. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1878028 · Cited by 102
Sharp, P. M., Plenderleith, L. J., & Hahn, B. H. (2020) · Annual Review of Microbiology · doi:10.1146/annurev-micro-020518-115628 · Cited by 96
Neurological Complications of Malaria
Trivedi, S., & Chakravarty, A. (2022) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-022-01214-6 · Cited by 90
The global burden of Plasmodium vivax malaria is obscure and insidious
Battle, K. E., & Baird, J. K. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003799 · Cited by 85
Self-citationWeiss, D. J., Dzianach, P. A., Saddler, A., Lubinda, J., Browne, A. J., McPhail, M., Rumisha, S. F., Sanna, F., Gelaw, Y. A., Kiss, J. B., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00038-8 · Cited by 86
Self-citationTreatment and prevention of malaria in children
Ashley, E. A., & Poespoprodjo, J. R. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30127-9 · Cited by 83
Tracking spending on malaria by source in 106 countries, 2000–16: an economic modelling study
Haakenstad, A., Harle, A. C., Tsakalos, G., Micah, A. E., Tao, T., Anjomshoa, M., Cohen, J. L., Fullman, N., Hay, S. I., Meštrović, T., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30165-3 · Cited by 87
The enigmatic mechanisms by which Plasmodium vivax infects Duffy-negative individuals
Popovici, J., Roesch, C., & Rougeron, V. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008258 · Cited by 79
Malaria in Southern Venezuela: The hottest hotspot in Latin America
Grillet, M. E., Moreno, J. E., Hernández-Villena, J. V., Vincenti-Gonzalez, M. F., Noya, Ó., Tami, A., Paniz‐Mondolfi, A., Llewellyn, M. S., Lowe, R., Escalante, A. A., et al. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008211 · Cited by 80
The immunology of Plasmodium vivax malaria
Antonelli, L. R. D. V., Junqueira, C., Vinetz, J. M., Golenbock, D. T., Ferreira, M. U., & Gazzinelli, R. T. (2019) · Immunological Reviews · doi:10.1111/imr.12816 · Cited by 82
Asma, S., Lozano, R., Chatterji, S., Swaminathan, S., Marinho, M. D. F. J., Yamamoto, N., Varavikova, E. A., Misganaw, A., Ryan, M. J., Dandona, L., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32523-1 · Cited by 74
Commons, R. J., Rajasekhar, M., Edler, P., Abreha, T., Awab, G. R., Baird, J. K., Barber, B. E., Chu, C. S., Cui, L., Daher, A. B., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00430-9 · Cited by 70
Reddy, V., Weiss, D. J., Rozier, J., ter Kuile, F. O., & Dellicour, S. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(22)00431-4 · Cited by 68
Self-citationMonitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions
Ferreira, M. U., de Sousa, T. N., Rangel, G. W., Johansen, I. C., Corder, R. M., Ladeia-Andrade, S., & Gil, J. P. (2020) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2020.12.001 · Cited by 68
Plasmodium vivax – How hidden reservoirs hinder global malaria elimination
Angrisano, F., & Robinson, L. J. (2021) · Parasitology International · doi:10.1016/j.parint.2021.102526 · Cited by 66
Benavente, E. D., Mańko, E., Phelan, J. E., Campos, M., Nolder, D., Fernandez, D. M., Tobón, G. J. V., Tobón-Castaño, A., Dombrowski, J. G., Marinho, C. R. F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23422-3 · Cited by 60
Hossain, M. S., Commons, R. J., Douglas, N. M., Thriemer, K., Alemayehu, B. H., Amaratunga, C., Anvikar, A. R., Ashley, E. A., Asih, P. B. S., Carrara, V. I., et al. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003393 · Cited by 55
Plasmodium vivax chloroquine resistance links to pvcrt transcription in a genetic cross
Sá, J. M., Kaslow, S. R., Barros, R. R. M., Brazeau, N. F., Parobek, C. M., Tao, D., Salzman, R. E., Gibson, T. J., Murugan, V., Krause, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12256-9 · Cited by 52
Plasmodium vivax Malaria Viewed through the Lens of an Eradicated European Strain
van Dorp, L., Gelabert, P., Rieux, A., de Manuel, M., de-Dios, T., Gopalakrishnan, S., Carøe, C., Sandoval‐Velasco, M., Fregel, R., Olalde, Í., et al. (2019) · Molecular Biology and Evolution · doi:10.1093/molbev/msz264 · Cited by 53
Al‐Mekhlafi, H. M., Madkhali, A. M., Ghailan, K. Y., Abdulhaq, A. A., Ghzwani, A. H., Zain, K. A., Atroosh, W. M. M., Alshabi, A., Khadashi, H. A., Darraj, M. A., et al. (2021) · Malaria Journal · doi:10.1186/s12936-021-03846-4 · Cited by 51
Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure
Thriemer, K., Ley, B., & von Seidlein, L. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003494 · Cited by 51
An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples
MalariaGEN, Adam, I., Alam, M. S., Alemu, S. G., Amaratunga, C., Amato, R., Andrianaranjaka, V., Anstey, N. M., Aseffa, A., Ashley, E. A., et al. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17795.1 · Cited by 48
Guidelines for the purification and characterization of extracellular vesicles of parasites
Fernández-Becerra, C., Xander, P. B., Alfandari, D., Dong, G., Aparici‐Herraiz, I., Rosenhek‐Goldian, I., Shokouhy, M., Gualdrón‐López, M., Lozano, N., Cortes-Serra, N., et al. (2023) · Journal of Extracellular Biology · doi:10.1002/jex2.117 · Cited by 66
Arambepola, R., Keddie, S., Collins, E. L., Twohig, K. A., Amratia, P., Bertozzi-Villa, A., Chestnutt, E. G., Harris, J., Millar, J. J., Rozier, J. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-75189-0 · Cited by 46
Population genomic evidence of Plasmodium vivax Southeast Asian origin
Daron, J., Boissière, A., Boundenga, L., Ngoubangoye, B., Houzé, S., Arnathau, C., Sidobre, C., Trape, J., Durand, P., Renaud, F., et al. (2021) · Science Advances · doi:10.1126/sciadv.abc3713 · Cited by 44
Rajasekhar, M., Simpson, J. A., Ley, B., Edler, P., Chu, C. S., Abreha, T., Awab, G. R., Baird, J. K., Bancone, G., Barber, B. E., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00431-0 · Cited by 42
Auburn, S., Cheng, Q., Marfurt, J., & Price, R. N. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003560 · Cited by 42
Poespoprodjo, J. R., Burdam, F. H., Candrawati, F., Ley, B., Meagher, N., Kenangalem, E., Indrawanti, R., Trianty, L., Thriemer, K., Price, D. J., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00358-3 · Cited by 46
Serology for Plasmodium vivax surveillance: A novel approach to accelerate towards elimination
Tayipto, Y., Liu, Z. S.-J., Müeller, I., & Longley, R. J. (2021) · Parasitology International · doi:10.1016/j.parint.2021.102492 · Cited by 42
Plasmodium vivax Liver and Blood Stages Recruit the Druggable Host Membrane Channel Aquaporin-3
Posfai, D., Maher, S. P., Roesch, C., Vantaux, A., Sylvester, K., Péneau, J., Popovici, J., Kyle, D. E., Witkowski, B., & Derbyshire, E. R. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.03.009 · Cited by 43
African Plasmodium vivax malaria improbably rare or benign
Baird, J. K. (2022) · Trends in Parasitology · doi:10.1016/j.pt.2022.05.006 · Cited by 40
Mapping malaria seasonality in Madagascar using health facility data
Nguyen, H. L. T., Howes, R. E., Lucas, T. C. D., Battle, K. E., Cameron, E., Gibson, H. S., Rozier, J. A., Keddie, S., Collins, E., Arambepola, R., et al. (2020) · BMC Medicine · doi:10.1186/s12916-019-1486-3 · Cited by 45
Self-citationThe epidemiology of Plasmodium vivax among adults in the Democratic Republic of the Congo
Brazeau, N. F., Mitchell, C. L., Morgan, A. P., Deutsch-Feldman, M., Watson, O. J., Thwai, K. L., Gelabert, P., van Dorp, L., Keeler, C., Waltmann, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24216-3 · Cited by 42
Plasmodium vivax epidemiology in Ethiopia 2000-2020: A systematic review and meta-analysis
Ketema, T., Bacha, K., Getahun, K., Portillo, H. A. D., & Bassat, Q. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009781 · Cited by 44
The genomic signatures of natural selection in admixed human populations
Cuadros-Espinoza, S., Laval, G., Quintana‐Murci, L., & Patin, É. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.02.011 · Cited by 41
Danwang, C., Bigna, J. J., Nzalie, R. N. T., & Robert, A. R. (2020) · Malaria Journal · doi:10.1186/s12936-020-03373-8 · Cited by 39
Mehdipour, P., Rajasekhar, M., Dini, S., Zaloumis, S. G., Abreha, T., Adam, I., Awab, G. R., Baird, J. K., Brasil, L. W., Chu, C. S., et al. (2023) · Malaria Journal · doi:10.1186/s12936-023-04725-w · Cited by 42
Lo, E. Y. Y., Russo, G., Pestana, K., Kepple, D., Abagero, B. R., Dongho, G. B. D., Gunalan, K., Miller, L. H., Hamid, M. M. A., Yewhalaw, D., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.05.009 · Cited by 39
Golassa, L., Amenga-Etego, L. N.-K., Lo, E. Y. Y., & Amambua‐Ngwa, A. (2020) · Malaria Journal · doi:10.1186/s12936-020-03372-9 · Cited by 39
Obadia, T., Nekkab, N., Robinson, L. J., DRAKELEY, C. J., Müeller, I., & White, M. T. (2022) · BMC Medicine · doi:10.1186/s12916-022-02285-5 · Cited by 37
Almeida, G. G., Costa, P. A. C., Araújo, M. D. S., Gomes, G. R., de Carvalho, A. F., Figueiredo, M. M., Pereira, D. B., Tada, M. S., Medeiros, J. F., Soares, I. S., et al. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009077 · Cited by 34
The Gini coefficient as a useful measure of malaria inequality among populations
Abeles, J., & Conway, D. J. (2020) · Malaria Journal · doi:10.1186/s12936-020-03489-x · Cited by 35
Segev-Zarko, L.-A. T., Dahlberg, P. D., Sun, S., Pelt, D. M., Kim, C. Y., Egan, E. S., Sethian, J. A., Chiu, W., & Boothroyd, J. C. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac183 · Cited by 35
Sadhewa, A., Cassidy-Seyoum, S. A., Acharya, S., Devine, A., Price, R. N., Mwaura, M., Thriemer, K., & Ley, B. (2023) · Pathogens · doi:10.3390/pathogens12050650 · Cited by 34
A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax
Kunkeaw, N., Nguitragool, W., Takashima, E., Kangwanrangsan, N., Muramatsu, H., Tachibana, M., Ishino, T., Lin, P. J. C., Tam, Y. K., Pichyangkul, S., et al. (2023) · npj Vaccines · doi:10.1038/s41541-023-00786-9 · Cited by 34
A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria
Trimarsanto, H., Amato, R., Pearson, R. D., Sutanto, E., Noviyanti, R., Trianty, L., Marfurt, J., Pava, Z., Echeverry, D. F., Lopera-Mesa, T. M., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04352-2 · Cited by 34
Pfeffer, D. A., Satyagraha, A. W., Sadhewa, A., Alam, M. S., Bancone, G., Boum, Y., Brito, M. A. M., Cui, L., Deng, Z., Domingo, G. J., et al. (2022) · Pathogens · doi:10.3390/pathogens11091045 · Cited by 34
Quek, Z. B. R., & Ng, S. H. (2024) · Pathogens · doi:10.3390/pathogens13040275 · Cited by 29
Mapping socioeconomic inequalities in malaria in Sub-Sahara African countries
Carrasco‐Escobar, G., Fornace, K., & Benmarhnia, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-94601-x · Cited by 31
Thriemer, K., Degaga, T. S., Christian, M., Alam, M. S., Rajasekhar, M., Ley, B., Hossain, M. S., Kibria, M. G., Tego, T. T., Abate, D. T., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01553-2 · Cited by 31
Gore-Langton, G. R., Cano, J., Simpson, H., Tatem, A., Tejedor-Garavito, N., Wigley, A., Carioli, A., Gething, P., Weiss, D. J., Chandramohan, D., et al. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001061 · Cited by 30
Self-citationDevine, A., Pasaribu, A. P., Teferi, T., Pham, H.-T., Awab, G. R., Contantia, F., Nguyen, T.-N., Ngo, V. T. T., Tran, T.-H., Hailu, A., et al. (2019) · Bulletin of the World Health Organization · doi:10.2471/blt.18.226688 · Cited by 30
Zoonotic and vector-borne parasites and epilepsy in low-income and middle-income countries
Singh, G., Angwafor, S. A., NJAMNSHI, A. K., Fraimow, H. S., & Sander, J. W. A. S. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0361-3 · Cited by 30
Ford, A., Kepple, D., Abagero, B. R., Connors, J., Pearson, R. D., Auburn, S., Getachew, S., Ford, C. T., Gunalan, K., Miller, L. H., et al. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008234 · Cited by 30
Gumbo, A., Topazian, H. M., Mwanza, A., Mitchell, C. L., Puerto-Meredith, S. M., Njiko, R., Kayange, M., Mwalilino, D., Mvula, B., Tegha, G., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab353 · Cited by 26
Rougeron, V., Boundenga, L., Arnathau, C., Durand, P., François Renaud, A., & Prugnolle, F. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab047 · Cited by 29
Primaquine for Plasmodium vivax radical cure: What we do not know and why it matters
Popovici, J., Tebben, K., Witkowski, B., & Serre, D. (2021) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2020.12.004 · Cited by 30
Devine, A., Battle, K. E., Meagher, N., Howes, R. E., Dini, S., Gething, P. W., Simpson, J. A., Price, R. N., & Lubell, Y. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003614 · Cited by 31
Self-citationde Oliveira, T. C., Corder, R. M., Early, A. M., Rodrigues, P. T., Ladeia-Andrade, S., Alves, J. M. P., Neafsey, D. E., & Ferreira, M. U. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008808 · Cited by 27
Anjani, Q. K., Volpe‐Zanutto, F., Hamid, K. A., Sabri, A. H. B., Moreno-Castellano, N., Gaitan, X. A., Calit, J., Bargieri, D. Y., & Donnelly, R. F. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.08.009 · Cited by 27
Corder, R. M., de Lima, A. C. P., Khoury, D. S., Docken, S. S., Davenport, M. P., & Ferreira, M. U. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008526 · Cited by 26
Kepple, D., Hubbard, A., Ali, M. M., Abagero, B. R., López, K., Pestana, K., Janies, D. A., Yan, G., Hamid, M. M. A., Yewhalaw, D., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab063 · Cited by 26
Rae, J. D., Landier, J., Simpson, J. A., Proux, S., Devine, A., Maude, R. J., Thu, A. M., Wiladphaingern, J., Kajeechiwa, L., Thwin, M. M., et al. (2021) · BMC Public Health · doi:10.1186/s12889-021-11749-x · Cited by 26
Lee, S. H., Jarvis, C. I., Edmunds, W. J., Economou, T., & Lowe, R. (2021) · Journal of The Royal Society Interface · doi:10.1098/rsif.2021.0096 · Cited by 25
Wångdahl, A., Sondén, K., Wyss, K., Stenström, C., Bjorklund, D. F., Zhang, J. J., Askling, H. H., Carlander, C., Hellgren, U., & Färnert, A. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab610 · Cited by 25
Systems biology of malaria explored with nonhuman primates
Galinski, M. R. (2022) · Malaria Journal · doi:10.1186/s12936-022-04199-2 · Cited by 25
Organoids for Liver Stage Malaria Research
Mellin, R., & Boddey, J. A. (2019) · Trends in Parasitology · doi:10.1016/j.pt.2019.12.003 · Cited by 28
Single-cell RNA sequencing reveals developmental heterogeneity among Plasmodium berghei sporozoites
Ruberto, A. A., Bourke, C., Mérienne, N., Obadia, T., Amino, R., & Müeller, I. (2021) · Scientific Reports · doi:10.1038/s41598-021-82914-w · Cited by 24
Ruberto, A. A., Bourke, C., Vantaux, A., Maher, S. P., Jex, A. R., Witkowski, B., Snounou, G., & Müeller, I. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010633 · Cited by 22
Plasmodium vivax Duffy Binding Protein-Based Vaccine: a Distant Dream
Kar, S., & Sinha, A. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.916702 · Cited by 21
Silke, F., Earl, L., Hsu, J., Janko, M., Joffe, J., Memetova, A., Michael, D., Zheng, P., Aravkin, A. Y., Murray, C. J. L., et al. (2024) · The Lancet Global Health · doi:10.1016/s2214-109x(24)00181-5 · Cited by 21
He, X. C., Pan, M., Zeng, W., Zou, C., Pi, L., Qin, Y., Zhao, L., Qin, P., Lu, Y., Baird, J. K., et al. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4357-9 · Cited by 20
Single-genome sequencing reveals within-host evolution of human malaria parasites
Dia, A., Jett, C., Trevino, S. G., Chu, C. S., Sriprawat, K., Anderson, T. J. C., Nosten, F. H., & Cheeseman, I. H. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2021.08.009 · Cited by 20
Mapping tuberculosis prevalence in Ethiopia using geospatial meta-analysis
Alene, K. A., Python, A., Weiss, D. J., Elagali, A. E. M., Wagaw, Z. A., Kumsa, A., Gething, P. W., & Clements, A. (2023) · International Journal of Epidemiology · doi:10.1093/ije/dyad052 · Cited by 20
Diagnosis and management of malaria in the intensive care unit
Akafity, G., Kumi, N., & Ashong, J. (2023) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2023.09.002 · Cited by 22
dos Santos, R. O., da Cruz, M. G. S., Lopes, S. C. P., Oliveira, L. B., Nogueira, P. A., Lima, É. S., Soares, I. S., Kano, F. S., Teixeira‐Carvalho, A., Costa, F. T. M., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00400 · Cited by 19
A simulation study of disaggregation regression for spatial disease mapping
Arambepola, R., Lucas, T. C. D., Nandi, A. K., Gething, P. W., & Cameron, E. (2021) · Statistics in Medicine · doi:10.1002/sim.9220 · Cited by 19
Amoah, L. E., Asare, K. K., Donu, D., Anang, S.-F., Busayo, A., Bredu, D., Asumah, G. A., Peprah, N. Y., Asamoah, A., Abuaku, B. K., et al. (2022) · Parasites & Vectors · doi:10.1186/s13071-022-05153-6 · Cited by 20
Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria
Ley, B., Alam, M. S., Satyagraha, A. W., Phru, C. S., Thriemer, K., Tadesse, D., Shibiru, T., Hailu, A., Kibria, M. G., Hossain, M. S., et al. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010406 · Cited by 19
Mathematical models of Plasmodium vivax transmission: A scoping review
Anwar, M. N., Smith, L., Devine, A., Mehra, S., Walker, C. R., Ivory, E., Conway, E. J., Müeller, I., McCaw, J. M., Flegg, J. A., et al. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011931 · Cited by 24
Ley, B., Alam, M. S., Kibria, M. G., Marfurt, J., Phru, C. S., Ami, J. Q., Thriemer, K., Auburn, S., Jahan, N., Johora, F. T., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003576 · Cited by 19
Nelli, L., Guelbeogo, M. W., Ferguson, H. M., Ouattara, D., Tiono, A. B., N’Falé, S., & Matthiopoulos, J. (2020) · International Journal of Health Geographics · doi:10.1186/s12942-020-00209-1 · Cited by 19
Tafenoquine for the treatment of Plasmodium vivax malaria
Llanos‐Cuentas, A., Manrique, P., Rosas-Aguirre, Á. M., Herrera, S., & Hsiang, M. S. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2058394 · Cited by 19
Ibeji, J. U., Mwambi, H. G., & Iddrisu, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-15561-4 · Cited by 18
Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review
Drysdale, M., Tan, L., Martin, A., Fuhrer, I., Duparc, S., & Sharma, H. (2022) · Infectious Disease and Therapy · doi:10.1007/s40121-022-00713-w · Cited by 15
Shukla, M., Rathi, K., Hassam, M., Yadav, D. K., Karnatak, M., Rawat, V., & Verma, V. P. (2023) · Medicinal Research Reviews · doi:10.1002/med.21979 · Cited by 18
Golumbeanu, M., Edi, C., Hetzel, M. W., Koepfli, C., & Nsanzabana, C. (2023) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.22-0749 · Cited by 22
Cameron, E., Young, A. J., Twohig, K. A., Pothin, E., Bhavnani, D., Dismer, A., Merilien, J. B., Hamre, K. E. S., Meyer, P., Menach, A. L., et al. (2021) · eLife · doi:10.7554/elife.62122 · Cited by 19
Self-citationSuratanee, A., Buaboocha, T., & Plaimas, K. (2021) · Bioinformatics and Biology Insights · doi:10.1177/11779322211013350 · Cited by 18
Metadata
- Authors
- Battle, K. E., Lucas, T. C. D., Nguyen, M., Howes, R. E., Nandi, A. K., Twohig, K. A., Pfeffer, D. A., Cameron, E., Rao, P. C., Casey, D., Gibson, H. S., Rozier, J. A., Dalrymple, U., Keddie, S. H., Collins, E. L., Harris, J. R., Guerra, C. A., Thorn, M. P., Bisanzio, D., Fullman, N., Huynh, C. K., Kulikoff, X., Kutz, M. J., Lopez, A. D., Mokdad, A. H., Naghavi, M., Nguyen, G., Shackelford, K. A., Vos, T., Wang, H., Lim, S. S., Murray, C. J. L., Price, R. N., Baird, J. K., Smith, D. L., Bhatt, S., Weiss, D. J., Hay, S. I., & Gething, P. W.
- Affiliations
- University of Oxford (GB)
- Charles Darwin University (AU)
- University of Washington (US)
- Public Health – Seattle & King County (US)
- Public Health England (GB)
- Medical Care Development International (US)
- University of Nottingham (GB)
- Imperial College London (GB)
- Corresponding author
- Gething, Peter W
- ORCID
- Battle, Katherine E
- Lucas, Tim C D
- Howes, Rosalind E
- Nandi, Anita K
- Twohig, Katherine A
- Pfeffer, Daniel A
- Cameron, Ewan
- Gibson, Harry S
- Rozier, Jennifer A
- Dalrymple, Ursula
- Keddie, Suzanne H
- Guerra, Carlos A
- Bisanzio, Donal
- Fullman, Nancy
- Kulikoff, Xie
- Mokdad, Ali H
- Naghavi, Mohsen
- Vos, Theo
- Wang, Haidong
- Lim, Stephen S
- Murray, Christopher J L
- Price, Ric N
- Baird, J Kevin
- Smith, David L
- Bhatt, Samir
- Weiss, Daniel J
- Hay, Simon I
- Gething, Peter W
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 394
- Issue
- 10195
- Pages
- 332-343
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC6675736
- OpenAlex
- W2950607694
- Cited by
- 409
- References
- 36
- Citations by year
- 2026: 31 · 2025: 41 · 2024: 63 · 2023: 69 · 2022: 59 · 2021: 83 · 2020: 49 · 2019: 14
- FWCI
- 47.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Lancet (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Funders
- Bill and Melinda Gates Foundation
- Wellcome Trust (200909/Z/16/Z, 200909)
- Medical Research Council (MR/R015600/1)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Life Sciences › Immunology and Microbiology › Parasitology › Bird parasitology and diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Travel-related health issues
- Keywords
- Plasmodium vivax, vivax malaria, malaria endemicity, clinical burden, Plasmodium falciparum, malaria elimination, global burden of disease, sub-Saharan Africa, Americas, Southeast Asia, western Pacific, socio-economic instability
- MeSH terms
- Africa, Americas, Asia, Southeastern, Bayes Theorem, Humans, Population Surveillance, Global Health, Malaria, Vivax, Endemic Diseases, Oceania, Spatio-Temporal Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
